Stimatix has developed low-profile innovative solutions for colostomy management, intended to improve the quality of life for people with stomas.
In November 2014, Stimatix sold its assets to a subsidiary company of the B. Braun Group, B. Braun Medical SAS. The Asset Purchase Agreement (APA) included a nondisclosure agreement that prevented release of information; however, with an international market launch of the Stimatix product planned for mid-2018, B. Braun authorized disclosure by Trendlines of the fact that B. Braun was the acquirer. B. Braun Medical SAS is the location of the company’s Stoma Care Center of Excellence.
B. Braun, one of the world’s leading providers and manufacturers of health care solutions, is in the process of completing a high-volume manufacturing facility for the production of the Stimatix products.
Read the full announcement (PDF).
Awards: 2011, Best Start-Up, Israel’s Office of the Chief Scientist of the Ministry of Economy
Preventing the development of pressure sores
Novel treatment for vertebral compression fractures
Preventing catheter-associated urinary tract infections (CAUTIs)
Wireless, wearable vital sign monitoring system
Cryotherapy for superficial bladder cancer
Endoscopic ultrasound fine needle biopsy system
Device to prevent preterm birth